Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Bortezomib is a promising anticancer drug targeting the proteasome.
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Numéro d'article: 19018753

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Numéro d'article: 19018753

DJF 20919

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from États-Unis

En stock
États-Unis Importé depuis la boutique USA

QTY:

Commandez maintenant et recevez votre commande aux alentours du Mardi, Août 25
Nos meilleurs partenaires logistiques
  • fedex
  • dhl
Bortezomib is a promising anticancer drug targeting the proteasome.
Garantie U-Care :
Aucun
Sélectionnez un forfait
fast shipping

Livraison
rapide

free return

Retour
gratuit*

Emballage sécurisé

Emballage sécurisé

Produits 100 % originaux

Produits 100 % originaux

pci-dss

Conformité PCI DSS

iso certified

Certifié ISO 27001


paypal payment
visa payment
mastercard payment
Note: Step Down Voltage Transformer required for using electronics products of États-Unis store (110-120). Recommended power converters Acheter maintenant.

Ce qui se démarque

Comprehensive Overview
This edition provides an extensive examination of Bortezomib, detailing its development, mechanism, and therapeutic impact on multiple myeloma, making it an essential resource for healthcare professionals and researchers.
Evidence-Based Insights
Incorporates cutting-edge research and clinical trials, offering evidence-based insights that enhance understanding of Bortezomib’s efficacy and its role in treatment regimens, supporting informed decision-making in patient care.
Updated Protocols
Includes the latest treatment protocols and guidelines for using Bortezomib, ensuring that practitioners have current, best-practice information for integrating this drug into modern multiple myeloma therapy.

Détails du produit

Discover Bortezomib, a breakthrough drug for Multiple Myeloma treatment. Order now from Ubuy Djibouti and avail global delivery. Shop now!
  • Bortezomib is a promising anticancer drug targeting the proteasome
  • Induces cell stress and apoptosis in cancer cells
  • Valuable source of information for researchers and clinicians in oncology and pharmacology
  • Useful for those working in academia or the pharmaceutical industry
  • Focuses on the treatment of Multiple Myeloma (MM) using bortezomib
  • Offers insights into the mechanisms and potential benefits of proteasome inhibition
Publisher Springer
Publication date November 11, 2010
Edition 2011th
Language English
Print length 188 pages
ISBN-10 3764389478
ISBN-13 978-3764389475
Item Weight 15.2 ounces (430.92 grams)
Dimensions 6.2 x 0.6 x 9.4 inches (15.7 x 1.5 x 23.9 cm)
Part of series Milestones in Drug Therapy

À qui est-ce destiné ?

Suitable For
  • Healthcare Professionals

    Oncologists and healthcare professionals seeking comprehensive information on Bortezomib and its efficacy for treating multiple myeloma.

  • Medical Students

    Students studying oncology or drug therapy will benefit from detailed insights into Bortezomib's role in treatment protocols.

  • Patients and Caregivers

    Individuals affected by multiple myeloma who want to understand treatment options and experiences with Bortezomib.

Not Suitable For
  • General Public

    Individuals not involved in healthcare may find the technical content challenging and less relevant for general health understanding.

DESCRIPTION DU PRODUIT

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Vous avez une question ? Chattez avec nous

Questions et réponses des clients

  • question: What is Bortezomib and how does it work in treating Multiple Myeloma?

    répondre: Bortezomib is a proteasome inhibitor used as a chemotherapy drug in the treatment of Multiple Myeloma. It works by blocking the proteasome's function, leading to the accumulation of proteins that promote apoptosis, or programmed cell death, in cancer cells. This helps to hinder the growth of malignant plasma cells. In practice, patients may experience a reduction in tumor size and improvement in blood cell counts, making Bortezomib a pivotal part of combination therapies.
  • question: What are the side effects of Bortezomib?

    répondre: Common side effects of Bortezomib can include nausea, fatigue, nerve damage, and low blood cell counts. Understanding these potential effects allows patients and caregivers to be proactive in managing symptoms and coordinating care. For instance, if a patient experiences severe fatigue, adjustments to their daily schedule and lifestyle might be warranted to ensure they maintain a good quality of life during treatment.
  • question: How is Bortezomib administered to patients?

    répondre: Bortezomib can be administered via injection either subcutaneously or intravenously. The route and method depend on the specific treatment plan and the doctor's guidance. Patients might find subcutaneous injections more convenient as they can be less painful and simpler, helping to enhance compliance and ensuring the effectiveness of the therapy.
  • question: What is the significance of the 2011 edition in drug therapy milestones for Bortezomib?

    répondre: The 2011 edition highlights pivotal studies and advancements in the use of Bortezomib over the years. It showcases critical milestones, including its approval and combination with other therapies, which have shaped current treatment protocols. This edition serves not just as a historical reference but also provides insights for clinicians in optimizing treatment strategies for more effective outcomes.
  • question: Can Bortezomib be used in combination with other treatments?

    répondre: Yes, Bortezomib is often used in combination with other drugs such as dexamethasone and lenalidomide to enhance its effectiveness. This multi-drug approach is crucial as it attacks cancer cells from various angles, potentially leading to better remission rates. Combining therapies allows for more tailored treatment plans based on individual responses, expanding options for patients facing Multiple Myeloma.
  • question: What should I know about monitoring while on Bortezomib therapy?

    répondre: Monitoring is essential during Bortezomib therapy due to its effects on blood counts and nerve health. Regular blood tests will help track changes and guide necessary adjustments in treatment. Additionally, patients should be vigilant for any new or worsening symptoms, enabling prompt medical response and management which is crucial for ensuring safe and effective treatment.
  • question: What lifestyle changes may support patients undergoing Bortezomib treatment?

    répondre: Patients are encouraged to maintain a balanced diet, stay hydrated, and engage in light physical activity as tolerated, all of which contribute to overall health during treatment. Stress management practices such as mindfulness and yoga can also be beneficial. These lifestyle choices help bolster the body’s response to treatment and enhance the overall well-being of individuals fighting Multiple Myeloma.
  • question: Is there a specific diet recommended for patients on Bortezomib?

    répondre: While there isn't a one-size-fits-all diet, a balanced intake rich in fruits, vegetables, lean proteins, and whole grains is generally recommended. Adequate nutrition can support immune function and help manage side effects such as nausea. For instance, consuming small, frequent meals can alleviate gastrointestinal discomfort, making it a practical strategy for those undergoing therapy.
  • question: Are there any support resources for patients receiving Bortezomib?

    répondre: Several organizations provide support for patients undergoing Multiple Myeloma treatment with resources such as educational materials, counseling, and community support groups. Connecting with such resources can offer emotional support and useful information, aiding patients in navigating their journey through treatment more effectively.
  • question: Where can I buy Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy 2011th Edition?

    répondre: You can purchase the 2011th Edition of Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy through Ubuy. Ubuy offers a user-friendly platform where you can find this specific edition, ensuring that you receive a reliable source for your medical literature needs, ultimately aiding in informed decisions about treatment.

Cell Biology Editorial Review

Aucune critique éditoriale trouvée

Avis et évaluations clients

5.0
1 évaluations des clients
  • 5 étoile
    100%
  • 4 étoile
    0%
  • 3 étoile
    0%
  • 2 étoile
    0%
  • 1 étoile
    0%

Donnez votre avis sur ce produit

Partagez votre avis avec d'autres clients

Platform Trust & Buyer Confidence

trustpilot logo
4.3/5 9200 + reviews
Read reviews
MA
Mohammad
Verified buyer

“Excellent quality and original too,when ubuy send original things I will appreciate that ,I very satisfied thank you”

23 July 2026 · via Trustpilot
CK
Chitra
Verified buyer

“The order and delivery progress was communicated very well. Package arrived within the estimated time. Products arrived as expected in good condition.”

22-Jul-26 · via Trustpilot
K
kund
Verified buyer

“Good supply of products. Safe payment methods, and shipment worldwide! Genuine products.”

23-Jul-26 · via Trustpilot
OO
Onesi
Verified buyer

“Was my first time buying a product from Ubuy, but I found it so helpful. This is reliable. Gonna place a new order!”

22 July 2026 · via Trustpilot
SJ
SAO JOHN
Verified buyer

“Ubuy is a great online platform to buy stuff. Reliable, fast delivery time and great value for money. I've been using Ubuy online shopping platform for three years now and will continue to do so.”

23 July 2026 · via Trustpilot
Paiement sécurisé Global Delivery Easy Returns Genuine Products

Historique des prix du produit

Informations importantes

  • Limitations : Pour les produits expédiés à l'international, veuillez noter que toute garantie du fabricant peut ne pas être valide ; les options de service du fabricant peuvent ne pas être disponibles ; les manuels, instructions et avertissements de sécurité des produits peuvent ne pas être dans les langues du pays de destination ; les produits (et les matériaux qui les accompagnent) peuvent ne pas être conçus conformément aux normes, spécifications et exigences d'étiquetage du pays de destination ; et les produits peuvent ne pas être conformes à la tension et aux autres normes électriques du pays de destination (nécessitant l'utilisation d'un adaptateur ou d'un convertisseur le cas échéant). Il incombe au destinataire de s'assurer que le produit peut être importé légalement dans le pays de destination. En cas de commande auprès d'Ubuy ou de ses filiales, le destinataire est l'importateur officiel et doit se conformer à toutes les lois et réglementations du pays de destination.
  • Tous les produits listés sur Ubuy ne sont pas à vendre, Ubuy étant un moteur de recherche mondial. Les produits sont soumis aux réglementations en matière d'exportation et de commerce.